Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons.

Previous studies have shown that brain derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) can enhance the survival of dopaminergic neurons in the ventral mesencephalon (VM). Here we compared several non-survival functions of the two factors in VM neurons in culture. We found that both BDNF and GDNF elicited an increase in the depolarization-induced release of dopamine, but had no effect on GABA release, in the VM cultures. BDNF, but not GDNF, significantly enhanced the expression of the calcium binding protein calbindin and synaptic protein SNAP25. In contrast, treatment of the cultures with GDNF, but not BDNF, elicited a marked fasciculation of the processes of the VM neurons. Thus, although both act on VM neurons, BDNF and GDNF have distinct functions.

[1]  W. Cass,et al.  GDNF Selectively Protects Dopamine Neurons over Serotonin Neurons Against the Neurotoxic Effects of Methamphetamine , 1996, The Journal of Neuroscience.

[2]  F. Hefti,et al.  Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Y. Barde,et al.  Physiology of the neurotrophins. , 1996, Annual review of neuroscience.

[4]  E. Arenas,et al.  Effects of BDNF and NT‐4/5 on Striatonigral Neuropeptides or Nigral GABA Neurons In Vivo , 1996, The European journal of neuroscience.

[5]  G. Yancopoulos,et al.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra , 1991, Nature.

[6]  B. Ponder,et al.  GDNF signalling through the Ret receptor tyrosine kinase , 1996, Nature.

[7]  C. Spenger,et al.  Comparison of the Effects of the Neurotrophins on the Morphological Structure of Dopaminergic Neurons in Cultures of Rat Substantia Nigra , 1995, The European journal of neuroscience.

[8]  B. Lu,et al.  Recent progress in studies of neurotrophic factors and their clinical implications , 1997, Journal of Molecular Medicine.

[9]  T. Boone,et al.  GFRα-2 and GFRα-3 Are Two New Receptors for Ligands of the GDNF Family , 1997, The Journal of Biological Chemistry.

[10]  R. Lindsay,et al.  Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System , 1992, Journal of neurochemistry.

[11]  M. Radeke,et al.  Immunocytochemical localization of TrkB in the central nervous system of the adult rat , 1997, The Journal of comparative neurology.

[12]  John L. Hudson,et al.  Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo , 1995, Brain Research Bulletin.

[13]  J. Langston,et al.  GDNF Induces a Dystonia-like State in Neonatal Rats and Stimulates Dopamine and Serotonin Synthesis , 1996, Neuron.

[14]  A. Granholm,et al.  Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons , 1995, The Journal of comparative neurology.

[15]  J. Cedarbaum,et al.  The Therapeutic Potential of Neurotrophic Factors in the Treatment of Parkinson's Disease , 1993, Experimental Neurology.

[16]  John L. Hudson,et al.  Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo , 1994, Neuroscience Letters.

[17]  L. Olson,et al.  Neurturin and Glial Cell Line-Derived Neurotrophic Factor Receptor-β (GDNFR-β), Novel Proteins Related to GDNF and GDNFR-α with Specific Cellular Patterns of Expression Suggesting Roles in the Developing and Adult Nervous System and in Peripheral Organs , 1997, The Journal of Neuroscience.

[18]  M. Martin-Iverson,et al.  Spontaneous Behaviours of Rats are Differentially Affected by Substantia Nigra Infusions of Brain‐derived Neurotrophic Factor and Neurotrophin‐3 , 1996, The European journal of neuroscience.

[19]  Jimi Adu,et al.  Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase , 1997, Nature.

[20]  L. Olson,et al.  Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo , 1995, Nature.

[21]  C. Y. Wang,et al.  Cloning and characterization of glial cell line-derived neurotrophic factor receptor-B: A novel receptor for members of glial cell line-derived neurotrophic factor family of neurotrophic factors , 1998, Neuroscience.

[22]  J. Milbrandt,et al.  TrnR2, a Novel Receptor That Mediates Neurturin and GDNF Signaling through Ret , 1997, Neuron.

[23]  B. Hoffer,et al.  Functional recovery in parkinsonian monkeys treated with GDNF , 1996, Nature.

[24]  A. Buj-Bello,et al.  Characterization of a multicomponent receptor for GDNF , 1996, Nature.

[25]  K. Kuriyama,et al.  Nitric Oxide‐Induced [3H]GABA Release from Cerebral Cortical Neurons Is Mediated by Peroxynitrite , 1995, Journal of neurochemistry.

[26]  J. Fawcett,et al.  GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. , 1996, Neuroreport.

[27]  C. Shults,et al.  BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine , 1995 .

[28]  C. Sirrenberg,et al.  Neurotrophins Stimulate the Release of Dopamine from Rat Mesencephalic Neurons via Trk and p75Lntr Receptors* , 1996, The Journal of Biological Chemistry.

[29]  X. Breakefield,et al.  Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease , 1995, Brain Research.

[30]  Thomas C. Südhof,et al.  The synaptic vesicle cycle: a cascade of protein–protein interactions , 1995, Nature.

[31]  M. Levivier,et al.  Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  D. Gash,et al.  GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo , 1995, Brain Research.

[33]  S. Shimohama,et al.  Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. , 1995, Neurosurgery.

[34]  R. Lindsay,et al.  The Neurotrophins NT-4/5 and BDNF Augment Serotonin, Dopamine, and GABAergic Systems during Behaviorally Effective Infusions to the Substantia Nigra , 1994, Experimental Neurology.

[35]  A. Palotie,et al.  Cloning, mRNA Distribution and Chromosomal Localisation of the Gene for Glial Cell Line-Derived Neurotrophic Factor Receptor β, a Homologue to GDNFR-α , 1997 .

[36]  Rhonda,et al.  Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  F. Collins,et al.  Purification and Initial Characterization of Rat B49 Glial Cell Line‐Derived Neurotrophic Factor , 1994, Journal of neurochemistry.

[38]  S. Wiegand,et al.  Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Arenas,et al.  Functional receptor for GDNF encoded by the c-ret proto-oncogene , 1996, Nature.

[40]  J. West,et al.  Glial-derived neurotrophic factor rescues calbindin-D28k-immunoreactive neurons in alcohol-treated cerebellar explant cultures. , 1997, Journal of neurobiology.

[41]  F. Hefti,et al.  Pharmacology of neurotrophic factors. , 1997, Annual review of pharmacology and toxicology.

[42]  J. Morgan,et al.  The Ca2+ binding protein, frequenin is a nervous system-specific protein in mouse preferentially localized in neurites. , 1997, Brain research. Molecular brain research.

[43]  Y. Li,et al.  Cultured hippocampal neurons show responses to BDNF, NT-3, and NT-4, but not NGF , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[44]  E. Arenas,et al.  Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage , 1996, Neuroscience.

[45]  N. Belluardo,et al.  Complementary and Overlapping Expression of Glial Cell Line-Derived Neurotrophic Factor (GDNF), c-ret Proto-Oncogene, and GDNF Receptor-α Indicates Multiple Mechanisms of Trophic Actions in the Adult Rat CNS , 1997, The Journal of Neuroscience.

[46]  R. Vandlen,et al.  Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain , 1995, Nature.

[47]  R. Vejsada,et al.  Persephin, a Novel Neurotrophic Factor Related to GDNF and Neurturin , 1998, Neuron.

[48]  J. Louis,et al.  GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF , 1996, Cell.

[49]  A. Whitty,et al.  Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  B. Davidson,et al.  Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy , 1997, Science.

[51]  B J Hoffer,et al.  Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. , 1996, The Journal of pharmacology and experimental therapeutics.

[52]  L. Facci,et al.  Brain‐derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5‐trihydroxyphenylalanine‐induced injury , 1993, Journal of neuroscience research.

[53]  M. Beal,et al.  Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration. , 1996, Cell transplantation.

[54]  M. Barbacid,et al.  Nerve growth factor: a tale of two receptors. , 1993, Oncogene.

[55]  A. Björklund,et al.  Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A. Björklund,et al.  Short-Term GDNF Treatment Provides Long-Term Rescue of Lesioned Nigral Dopaminergic Neurons in a Rat Model of Parkinson’s Disease , 1996, The Journal of Neuroscience.

[57]  E. Arenas,et al.  Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons , 1995, The Journal of cell biology.

[58]  E. Pothos,et al.  Presynaptic Recording of Quanta from Midbrain Dopamine Neurons and Modulation of the Quantal Size , 1998, The Journal of Neuroscience.

[59]  M. Chao.  Neurotrophin receptors: A window into neuronal differentiation , 1992, Neuron.

[60]  Barbara Moffat,et al.  A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor , 1997, Nature.

[61]  R. McKay,et al.  Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus , 1992, Neuron.

[62]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[63]  S. Jiao,et al.  Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases , 1996, Cell and Tissue Research.

[64]  G. Gerhardt,et al.  In VivoMicrodialysis Studies of Somatodendritic Dopamine Release in the Rat Substantia Nigra: Effects of Unilateral 6-OHDA Lesions and GDNF , 1997, Experimental Neurology.